Reversal of multidrug resistance by 7-O-Benzoylpyripyropene A in multidrug-resistant tumor cells

13Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

7-O-Benzoylpyripyropene A (7-O-BzP), a semi-synthetic analog of pyripyropene, was investigated for its reversing effect on multidrug-resistant (MDR) tumor cells. 7-O-BzP (6.25 μg/ml) completely reversed resistance against vincristine and adriamycin in vincristine-resistant KB cells (VJ-300) and adriamycin-resistant P388 cells (P388/ADR), respectively. 7-O-BzP alone had no effect on the growth of drug sensitive and drug-resistant cells. 7-O-BzP (6.25 μg/ml) significantly enhanced accumulation of [3H]vincristine in VJ-300 cells and completely inhibited the binding of [3H]azidopine to the P-glycoprotein in VJ-300 cells and P388/ADR cells. The result suggests that 7-O-BzP effectively reverses P-glycoprotein-related MDR by interacting directly with P-glycoprotein in drug resistant VJ-300 and P388/ADR cells.

Cite

CITATION STYLE

APA

Rho, M. C., Hayashi, M., Fukami, A., Obata, R., Sunazuka, T., Tomoda, H., … Omura, S. (2000). Reversal of multidrug resistance by 7-O-Benzoylpyripyropene A in multidrug-resistant tumor cells. Journal of Antibiotics, 53(10), 1201–1206. https://doi.org/10.7164/antibiotics.53.1201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free